据港交所文件，拨康视云再次向港交所提交上市申请书，联席保荐人为建银国际、华泰国际。 ...

文/梧桐数据中心 2025年1-5月，共计有29家公司登陆港交所，其中27家通过IPO方式上市，另有1家通过借壳SPAC上市（找钢集团-Ｗ），1家GEM转主板上市（比优集团），这两 家不纳入本次统计中。港股首发上市的27家公司的IPO中介机构包括23家券商、21家香港律师事务所、15家中国内地律师事务所、6家审计机构，其中，中金公司 保荐8单，位列第一，华泰国际6单、招银国际5单，位列二三；达维律所和通商律所分别占据香港、中国法律顾问之首，业务单数各5单；"四大"则包揽了近90%的 审计业务，安永、毕马威各9单，德勤、罗兵咸永道各3单。 一、保荐人业绩排名 2025年1-5月，共有23家保荐人为这27家香港IPO上市公司提供了保荐服务，其中联合保荐的拆开计算，各计1单。 榜单前三名： 第一名：中金公司（8单） 第二名：华泰国际（6单） 第三名：招银国际（5单） | 排名 | 保荐人 | 业务单数 | | --- | --- | --- | | - | 中金公司 | 8 | | 2 | 华泰国际 | 6 | | 3 | 招银国际 | 5 | | 4 1 | 中信证券 (香港) WOOD REE | | | 5 ...

利弗莫尔证券显示，药捷安康(南京)科技股份有限公司-B通过港交所上市聆讯，联席保荐人为 中信证 券、华泰国际。 ...

Core Viewpoint - The A-share IPO market has shown signs of recovery in 2025 after a prolonged downturn in 2024, with an increase in both the number of IPOs and the amount of capital raised compared to the previous year [1][3][8]. Group 1: A-share IPO Market Performance - In 2025, the total amount raised through IPOs, additional issuances, and convertible bonds in the A-share market reached 214.83 billion yuan, a year-on-year increase of 53.1% [3]. - As of June 8, 2025, 45 A-share companies have been sponsored for IPOs, representing a 12.5% increase from the previous year, with total fundraising amounting to 33.655 billion yuan, up approximately 19% year-on-year [3][4]. - The provinces with the highest number of IPOs include Zhejiang (10), Jiangsu (10), and Guangdong (9), with Zhejiang leading in fundraising at 9.693 billion yuan [3]. Group 2: Leading Securities Firms in A-share IPOs - The top three securities firms in A-share IPO underwriting amounts are CITIC Securities (79.18 billion yuan), Huatai United Securities (30.34 billion yuan), and CITIC Securities (26.74 billion yuan) [4][7]. - A total of 23 securities firms have participated in A-share IPOs in 2025, with CITIC Securities and Huatai United Securities leading in underwriting amounts and revenues [4][7]. - Four firms have reported IPO underwriting revenues exceeding 200 million yuan, namely CITIC Securities, Huatai United Securities, CITIC Securities, and Guotai Junan [4]. Group 3: Hong Kong IPO Market Performance - The Hong Kong IPO market has experienced remarkable growth, with a year-on-year increase of over 700% in fundraising during the first five months of 2025 [2][8]. - Chinese securities firms have significantly outperformed foreign banks in the Hong Kong IPO market, with over half of the underwriting firms being Chinese [2][9]. - The total number of new listings in the Hong Kong market is expected to reach around 80 in 2025, with fundraising estimated between 130 billion to 150 billion Hong Kong dollars [9].

Industry - The attractiveness of US assets is declining globally due to high foreign exchange hedging costs, leading investors to prefer their own country's bonds for better returns [1] - The US Treasury market is facing challenges from a deteriorating budget outlook and trade tensions, with foreign investors showing caution despite not fearing a default [1] - In the Hong Kong IPO market, 29 companies have listed this year, with 27 through IPOs, raising a total of HKD 77.346 billion, nearing last year's total [2] - Chinese investment banks are becoming dominant players in the Hong Kong IPO scene, with over half of the underwriting firms being Chinese, marking a shift from foreign banks [2] - A total of 171 companies have submitted applications to list on the Hong Kong Stock Exchange, with 145 currently in the hearing process [2] - In the electronics sector, 30 companies are expected to see net profit growth exceeding 50% this year, with significant interest from institutional investors [3] - The North American electronics industry's capital expenditures are expected to exceed forecasts, prompting domestic companies to follow suit [3] Company - Circle, the first stablecoin company, saw its stock surge 122.58% on its first day of trading on the NYSE, closing at USD 83.23, a 168.5% increase [4] - Circle's market capitalization exceeded USD 18 billion on its debut, with trading volume reaching approximately 46 million shares [4] - Controversy surrounds Kelun Pharmaceutical's ergothioneine capsules, with accusations of being a "fake drug" from a prominent academic, leading to a significant stock price increase for the company [5] - Following the death of its founder, Wahaha Group is undergoing a "de-Wahaha" transformation, with over 15 companies in its system ceasing operations and facing quality control issues [6]

中国经济网北京5月30日讯 钧达股份(002865.SZ)今日收报37.93元，跌幅2.59%。目前，该股股价 跌破2023年定增增发价。 钧达股份(02865.HK)2025年5月8日在港交所上市，最终发售价及配发结果公告显示，钧达股份发 售股份数目63,432,300股，其中，香港公开发售的最终发售股份数目6,343,300股，国际发售的最终发 售股份数目57,089,000股。 钧达股份的联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人是华泰 国际、招银国际、Deutsche Bank；整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人 及财务顾问是中信证券、中金公司；联席账簿管理人及联席牵头经办人是广发证券(香港)、富途证券、 复星国际证券、中银国际、建银国际、工银国际、富强证券、TradeGo Markets。 2018年12月26日，钧达股份发布的公开发行可转换公司债券上市公告书显示，本次发行可转换公 司债券募集资金已由保荐机构(主承销商)于2018年12月14日汇入公司指定的账户，北京中证天通会计 师事务所(特殊普通合伙)已对前述募集资金到账情况进行了验资。钧达股份 ...

Group 1 - The core viewpoint of the article is that Hand Return Group, a personal insurance intermediary service provider, has officially launched its IPO, planning to issue approximately 24.36 million shares at a price range of HKD 5.84 to HKD 8.08, with a listing date set for May 30 on the Hong Kong Stock Exchange [2] - The global offering consists of about 90% international placement (approximately 21.92 million shares) and 10% for public offering in Hong Kong (approximately 2.44 million shares), with cornerstone investors Tianjin Haitai Group and Luch Capital subscribing for a total of approximately HKD 49.55 million [2] - Based on the median issue price of HKD 7.28, the company's market capitalization post-listing is estimated to be around HKD 1.648 billion (approximately RMB 1.517 billion), with a price-to-sales (PS) ratio of 1.09 and a price-to-earnings (PE) ratio of 6.27 [2] Group 2 - According to the prospectus, Hand Return Group's revenue for 2022, 2023, and 2024 is projected to be RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion, respectively, with adjusted net profits of RMB 75 million, RMB 253 million, and RMB 242 million, indicating a rising adjusted net profit margin reaching 17.4% by 2024 [3] - The company utilizes a digital platform to provide personal insurance transaction and service solutions, operating three major platforms: Xiao Yusan (online direct sales), Kachabao (agent distribution), and Niubao 100 (partner distribution), with over 1,900 insurance products distributed by the end of 2024 [3] - In 2023, the scale of personal insurance premiums in China reached RMB 500 billion, accounting for 14.6% of the total personal insurance market premiums, although the performance of insurance technology and intermediary platforms in the capital market has been mixed [3]

Core Viewpoint - Furuitek (Zhejiang) Intelligent Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, indicating its intention to go public [1] Company Summary - Furuitek (Zhejiang) Intelligent Technology Co., Ltd. is seeking to raise capital through an initial public offering (IPO) [1] - The company has engaged several joint sponsors for the listing, including CITIC Securities, CICC, Huatai International, and HSBC [1]

智通财经5月22日电，利弗莫尔证券显示，北京乐自天成文化发展股份有限公司向港交所提交上市申请 书，联席保荐人为花旗和华泰国际。 ...

5月15日，根据港交所披露，手回集团有限公司（以下简称"手回集团"）通过了港交所主板IPO聆讯。 GPLP犀牛财经注意到，手回集团的上市之路可谓一波三折。自2024年1月首次递表以来两度折戟，今年3月7日第三次更新招股书。据招股书，其联席保荐人 为中金公司与华泰国际，拟发行不超过7744.12万股普通股。 当前，港股对保险科技赛道虽持开放态度，但投资者更关注企业可持续盈利能力和合规经营水平。在互联网保险行业加速洗牌的背景下，手回集团的第三次 IPO闯关，或将决定其未来能否在头部竞争中站稳脚跟。 据招股书披露，2022年至2024年，手回集团营业收入分别为8.06亿元、16.34亿元、13.87亿元，呈现波动增长态势。净利润方面，手回集团2024年录得亏损 1.36亿元，连续两年累计亏损达4.92亿元。 除了业绩波动之外，手回集团旗下公司近年多次因违规受罚，包括向投保人提供额外利益、信息披露不充分等问题，暴露出内控薄弱风险。 2020年7月，原天津银保监局披露的信息显示，手回集团旗下小雨伞保险在2019年6月至8月期间，因向投保人提供保险合同约定之外的利益，被罚款12万 元。时任总经理光耀也因此受到警告，并被罚 ...